Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group. Academic Article uri icon

Overview

abstract

  • BACKGROUND: The purpose of this study was to investigate the toxicity and efficacy of the sequential administration of gemcitabine (GMB) in combination with cisplatin (CDDP) followed by docetaxel (Taxotere) as first-line treatment of advanced urothelial carcinoma. PATIENTS AND METHODS: Patients [aged

publication date

  • September 12, 2006

Research

keywords

  • Antimetabolites, Antineoplastic
  • Antineoplastic Combined Chemotherapy Protocols
  • Cisplatin
  • Deoxycytidine
  • Taxoids
  • Urologic Neoplasms

Identity

Scopus Document Identifier

  • 33750585961

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdl286

PubMed ID

  • 16968872

Additional Document Info

volume

  • 17

issue

  • 11